Literature DB >> 857581

Neuraxonal dystrophy of the brain in patients receiving antineoplastic chemotherapy.

H M Liu, J Loew, J Boggs.   

Abstract

The present report describes the neuropathological change found in the brainstem of four patients who were treated with combined chemotherapy for various types of malignant disease. The change consists of localized axonal swellings, the so-called "axonal spheroids" located predominantly in the medial lemniscus, the fibers from the olivary nuclei and around some of the cranial nerve nuclei. In addition to the brain change, all four patients had shown histological evidence of hepatic injury, although none of the patients exhibited overt clinical or chemical evidence of hepatic insufficiency. Neither did these patients show any clinical neurological deficit that could be related to the pathological findings. The neuroaxonal changes are most likely the result of altered metabolism as a consequence of the chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 857581     DOI: 10.1007/BF00686880

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  25 in total

1.  Glue-sniffing neuropathy.

Authors:  R Korobkin; A K Asbury; A J Sumner; S L Nielsen
Journal:  Arch Neurol       Date:  1975-03

Review 2.  Neurotoxicity of commonly used antineoplastic agents (first of two parts).

Authors:  H D Weiss; M D Walker; P H Wiernik
Journal:  N Engl J Med       Date:  1974-07-11       Impact factor: 91.245

3.  Therapeutic effect and toxicity of adriamycin in patients with neoplastic disease.

Authors:  J J Wang; E Cortes; L F Sinks; J F Holland
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

4.  Vinca alkaloid neuropathy: nerve biopsy studies in rats and in man.

Authors:  P G Gottschalk; P J Dyck; J M Kiely
Journal:  Neurology       Date:  1968-09       Impact factor: 9.910

5.  Encephalopathy in acute leukaemia associated with methotrexate therapy.

Authors:  H E Kay; P J Knapton; J P O'Sullivan; D G Wells; R F Harris; E M Innes; J Stuart; F C Schwartz; E N Thompson
Journal:  Arch Dis Child       Date:  1972-06       Impact factor: 3.791

6.  Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia.

Authors:  W A Bleyer; J C Drake; B A Chabner
Journal:  N Engl J Med       Date:  1973-10-11       Impact factor: 91.245

7.  Neurofibrillary pathology.

Authors:  H Wiśniewski; R D Terry; A Hirano
Journal:  J Neuropathol Exp Neurol       Date:  1970-04       Impact factor: 3.685

8.  Neurofibrillary degeneration of nerve cells after intracerebral injection of aluminium cream.

Authors:  H Wiśniewski; W Karczewski; K Wiśniewska
Journal:  Acta Neuropathol       Date:  1966-06-01       Impact factor: 17.088

9.  Toxic polyneuropathy produced by methyl N-butyl ketone.

Authors:  J R Mendell; K Saida; M F Ganansia; D B Jackson; H Weiss; R W Gardier; C Chrisman; N Allen; D Couri; J O'Neill; B Marks; L Hetland
Journal:  Science       Date:  1974-08-30       Impact factor: 47.728

10.  The mechanism of action of colchicine. Binding of colchincine-3H to cellular protein.

Authors:  G G Borisy; E W Taylor
Journal:  J Cell Biol       Date:  1967-08       Impact factor: 10.539

View more
  2 in total

1.  Diagnosis of juvenile-adult form of neuroaxonal dystrophy by electron microscopy of rectum and skin biopsy.

Authors:  G Schwendemann; G Arendt; J Noth; H W Lange; W Strauss
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

2.  Reactive neuroaxonal dystrophy in children. Clinical pathological correlation.

Authors:  H Mei Liu
Journal:  Acta Neuropathol       Date:  1978-06-30       Impact factor: 17.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.